CSIR-Central Drug Research Institute, Lucknow is a premier R&D Institute under the aegis of the Council of Scientific and Industrial Research (CSIR), New Delhi which is an autonomous body under Department of Scientific and Industrial Research, Government of India. It invites application from eligible candidates for filling up the post of Technical Assistant.
Name of the Post & Number of Vacancies
Technical Assistant: 16 vacancies
- Biometry and Statistics): 1 vacancy (Reserved for PWD- Locomotor disability or Cerebral palsy)
- S & T Management: 1 vacancy (Reserved for SC)
- Biological Sciences: 6 vacancies (3 Unreserved, 2 OBC and 1 PWD Hearing impairment)
- Lab Animals: 2 vacancies (01 OBC and 01 ST)
- SAIF: 1 vacancy (Reserved for SC)
- Chemical Sciences: 4 vacancies (2 Unreserved, 1 SC, and 1 OBC)
- Civil Maintenance: 1 vacancy (Reserved for SC)
Important Dates
Last date for sending application: 30 November 2011
Eligibility Criteria
Age Limit (as on 30 November 2011): Maximum 28 years
Application Fee: Application fee for General/ OBC category candidate is Rs 100 and no fee will be charged from SC/ST/Persons with Disabilities and CSIR employees.
The fee needs to be paid in the form of Banker Cheque/ Demand Draft only drawn in favour of "Director, Central Drug Research Institute" payable at Lucknow.
Pay Scale: Rs 9300-34800 (PB-2) + Grade Pay Rs 4200 per month. The total emolument at present is Rs 26558 (approx.).
How to Apply: Candidates should apply only on the prescribed format which can be down loaded from CSIR-CDRI website http://www.cdriindia.org/ The duly filled and signed application along with recent passport size photograph supported by the attested copies of certificates and testimonials should be sent in a sealed cover super scribed "Advertisement No. ___, Application for the post of _____, and Post Code ______" to the "Director, Central Drug Research Institute, Chattar Manzil Palace, Post Box No. 173, Lucknow - 226 001 (UP)".
For more details and application format, please CLICK HERE
Comments
All Comments (0)
Join the conversation